Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Proenca, CC"'
Publikováno v:
Therapeutics and Clinical Risk Management, Vol Volume 14, Pp 2265-2272 (2018)
Sara Bruce Wirta,1 Bogdan Balas,2 Catia C Proenca,3 Hollie Bailey,4 Zoe Phillips,4 James Jackson,4 Sarah Cotton4 1Real World Evidence, Cardio-Metabolic Franchise, Novartis Sweden, Stockholm, Sweden; 2Real World Evidence, Cardio-Metabolic Franchise, N
Externí odkaz:
https://doaj.org/article/24f8df46f7de45d082138740ebeae3ee
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 12, Pp 2311-2321 (2018)
James DS Jackson,1 Sarah E Cotton,1 Sara Bruce Wirta,2 Catia C Proenca,3 Milun Zhang,4 Raquel Lahoz,5 Bogdan Balas,5 Frederico J Calado5 1Real World Research, Adelphi Real World, Bollington, UK; 2Real World Evidence, Cardio-Metabolic Franchise, Novar
Externí odkaz:
https://doaj.org/article/49a3be385dda41a89a631051ca46b5c4
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 12, Pp 1669-1678 (2018)
James DS Jackson,1 Sarah E Cotton,1 Sara Bruce Wirta,2 Catia C Proenca,3 Milun Zhang,4 Raquel Lahoz,5 Frederico J Calado5 1Real World Research, Adelphi Real World, Bollington, Cheshire, UK; 2Real World Evidence Center of Excellence, Novartis Sweden A
Externí odkaz:
https://doaj.org/article/8b9ff99900ca4efe906c8c88cfdd2867
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 12, Pp 1659-1668 (2018)
James DS Jackson,1 Sarah E Cotton,1 Sara Bruce Wirta,2 Catia C Proenca,3 Milun Zhang,4 Raquel Lahoz,5 Frederico J Calado5 1Real World Research, Adelphi Real World, Bollington, UK; 2Real World Evidence, Cardio-Metabolics Franchise, Novartis Sweden AB,
Externí odkaz:
https://doaj.org/article/c88aef17b69446b09ab1be150a11144d
Publikováno v:
In Value in Health July 2022 25(7) Supplement:S512-S512
Publikováno v:
In Value in Health October-November 2017 20(9):A631-A631
Publikováno v:
In Value in Health October-November 2017 20(9):A623-A623
Publikováno v:
In Value in Health October-November 2017 20(9):A623-A623
Autor:
Gielen, V, Calado, F, Balas, B, Proenca, CC, Bruce Wirta, S, McMahon, P, Lucrezi, G, Richards, C, Croft, D
Publikováno v:
In Value in Health October-November 2017 20(9):A512-A512
Autor:
Eltokhi A; Departments of Molecular Neurobiology and Physiology, Max Planck Institute for Medical Research, Heidelberg, Germany.; Department of Pharmacolog, University of Washington, Seattle, WA, USA., Bertocchi I; Departments of Molecular Neurobiology and Physiology, Max Planck Institute for Medical Research, Heidelberg, Germany.; Department of Neuroscience Rita Levi Montalcini, University of Turin, 10126 Turin, Italy.; Neuroscience Institute - Cavalieri-Ottolenghi Foundation (NICO), Laboratory of Neuropsychopharmacology, Regione Gonzole 10, Orbassano, 10043 Torino, Italy., Rozov A; Departments of Molecular Neurobiology and Physiology, Max Planck Institute for Medical Research, Heidelberg, Germany.; Institute of Neuroscience, Lobachevsky State University of Nizhniy, 603022 Novgorod, Russia.; Federal Center of Brain Research and Neurotechnology, 117997 Moscow, Russia., Jensen V; Department of Molecular Medicine, Division of Physiology, Institute of Basic Medical Sciences, University of Oslo, 0372 Oslo, Norway., Borchardt T; Departments of Molecular Neurobiology and Physiology, Max Planck Institute for Medical Research, Heidelberg, Germany., Taylor A; Department of Experimental Psychology, University of Oxford, Oxford, UK., Proenca CC; Departments of Molecular Neurobiology and Physiology, Max Planck Institute for Medical Research, Heidelberg, Germany., Rawlins JNP; Department of Experimental Psychology, University of Oxford, Oxford, UK., Bannerman DM; Department of Experimental Psychology, University of Oxford, Oxford, UK., Sprengel R; Departments of Molecular Neurobiology and Physiology, Max Planck Institute for Medical Research, Heidelberg, Germany.
Publikováno v:
IScience [iScience] 2023 Oct 01; Vol. 26 (11), pp. 108116. Date of Electronic Publication: 2023 Oct 01 (Print Publication: 2023).